nephrectomy
Conditions
Interventions
Q:0.375% ropivacaine 20 ml
D1:0.375% ropivacaine 20 ml+ dexamethasone 0.1 mg/kg
D2:0.375% ropivacaine 20 ml+ dexmedetomidine hydrochloride 0.1 ug/kg
Sponsors
The Second Hospital of Lanzhou University
Eligibility
Sex/Gender
All
Age
25 Years to 75 Years
Inclusion criteria
Inclusion criteria: This study was approved by the ethics committee of our hospital, and the the patients signed informed consent. There were 138 patients with elective nephrectomy from December 2020 to June 2021, aged 25~65 years, and weight <= 80 kg, ASA II~III.
Exclusion criteria
Exclusion criteria: Exclude patients with history of congenital heart disease, diabetes, kidney disease, coagulation dysfunction, local anesthetic allergy, peripheral nervous system disease, severe bradycardia, hypertension grade iii, skin infection at puncture site-signatory informed consentnd and a variety of factors halfway out.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of remedial analgesics within 24 h after operation;vas scores of immediate (t0),2h (t1),4h (t2),8h (t3),16h (t4),24h (t5),48h (t6) were recorded;Cumulative dose of analgesic drugs;Pressing times of intravenous analgesia pump; | — |
Secondary
| Measure | Time frame |
|---|---|
| Immediate vas score after recovery;Time of First Remedial Analgesia;First water intake;First urination;First exhaust time;First time to get out of bed;Nausea frequency;Number of vomiting;Hematoma at puncture site;Temporary paralysis of the femoral nerve;Toxic response to local anesthetic;Patient satisfaction;age;weight;height;ASA;Total hospitalization days after operation; | — |
Countries
China
Contacts
Public ContactYisa Shi
The Second Hospital of Lanzhou University
Outcome results
None listed